1. Introduction
Alzheimer’s disease (AD) is the most common cause of dementia, characterized by slow onset and progressive decline of memory and cognitive functions. AD is associated with various cellular changes in the brain, including synaptic injury, alterations in mitochondrial structure and function, abnormal inflammatory response, extracellular accumulation of amyloid beta (Aβ), and intracellular neurofibrillary tangles [
1,
2,
3]. AD is caused by atrophy, senile plaques, and hyperphosphorylated tau protein aggregates in the hippocampus, one of the neuroanatomical areas responsible for memory and learning [
4,
5]. Cognitive dysfunction, including that involving memory and learning, is associated with decreased neurogenesis in the hippocampus, which could result from decreased expression of immature neuron factors, such as DCX (doublecortin), that signal the birth of new neurons [
6].
Tau overexpression and hyperphosphorylation have been found to impair axonal movement of cell organelles, including mitochondria [
7,
8,
9]. There has been much evidence demonstrating mitochondrial dysfunction accompanied by aging and aging-related neurodegenerative disease [
10]. In particular, mitochondrial dysfunction has been observed in fibroblasts and hematopoietic cells from the brains of AD transgenic mouse models and human patients with AD [
11,
12,
13,
14]. It has been suggested that mitochondrial dysfunction could develop when the course of AD worsens or in all stages of the disease, and that this process may occur not only in the brain, but systemically [
13].
In recent research on aging-related treatments, injection of young mouse blood into aged mice has shown positive effects, which may be applied as a new experimental approach for the treatment of aging-related diseases. According to previous studies, parabiosis between 18-month-old and 5-week-old mice resulted in increased expression of genes related to brain activity than in mice that did not receive blood transfusions, especially immediate-early genes in hippocampal cells [
15]. This indicated that parabiosis increased brain activity and improved memory. With increasing age, the synapses, which form the network for communication between neurons, begin to regress, leading to degeneration of neurons, atrophy of the brain, and a sudden increase in neurodegenerative disease. Blood links the diverse tissues of the body. Blood is not only a transport medium for oxygen and cells, but also helps to fight infectious disease and conveys information in the form of hormones and other molecules. In other words, blood plays an important role in conveying information between cells and tissues, including the brain.
Meanwhile, exercise not only has a positive effect in patients with neurodegenerative diseases such as AD and Parkinson’s disease, but also has positive effects on plasma. Exercise-induced neuroplasticity, characterized by inhibited apoptosis and increased neurogenesis and brain-derived neurotrophic factor (BDNF), facilitates recovery from brain damage after traumatic brain injury, ischemia, and stroke [
16,
17,
18,
19]. The plasma concentration of BDNF increases after aerobic exercise [
20], and exercise training has also been reported to increase resting plasma BDNF [
21]. As AD worsens, it eventually leads to loss of motor function. Although exercise has various positive effects on the brain, the drawback is that these effects are only possible when the individual is capable of physical activity. Thus, in this study, we aimed to examine whether transfusion of plasma from exercised mice could have similar effects to exercise on cognitive function, hippocampal neuroplasticity, and mitochondrial function in AD.
3. Discussion
Increasing evidence suggests that AD pathogenesis is not restricted to the neuronal compartment. Glial cells, particularly reactive astrocytes and activated microglia, appear to play critical and interactive roles in neurodegeneration [
22,
23]. Accumulating evidence of their role in brain energy metabolism and reduced oxygen supply to the brain clearly point to their critical involvement in the prevention, initiation, and progression of neurodegenerative diseases, including AD [
10,
24]. However, AD is an age-related neurodegenerative disease caused by accumulation of Aβ, neurofibrillary tangles, gradual nerve injury, and cognitive deficits. In 3xTg mice, we observed pathological elements similar to those of AD, including tau hyperphosphorylation and impaired spatial memory, which are consistent with previous studies [
25]. These symptoms have been reported to gradually worsen over time [
26]. Among the pathological elements of AD, overexpression and phosphorylation of tau is correlated with mitochondrial dysfunction including ROS production, reduced ATP, fragmenting of mitochondrial membrane potential, and ultimately, neuronal damage [
27,
28]. Specifically, elevated levels of ROS, including H
2O
2, resulting from impaired regulation of mitochondrial Ca
2+ homeostasis have been shown to increase the sensitivity of mitochondrial PTP opening [
29], which in turn promotes apoptosis [
30]. In the present study, the AD group showed tau hyperphosphorylation, reduced levels of synaptic plasticity markers such as BDNF, PSD95, and synaptophysin, reduced cell proliferation and neurogenesis, reduced mitochondrial Ca
2+ retention, and elevated H
2O
2. There were increased levels of Bax, apaf-1, cytochrome c, cleaved caspase-3 and -9, decreased Bcl-2 levels, and increased cell death in the AD group. In the hippocampus, tau hyperphosphorylation impairs cognitive function by not only inhibiting cell proliferation and neurogenesis, but also by increasing the number of cells undergoing apoptosis via mitochondrial dysfunction.
Various studies have demonstrated that exercise has positive effects on brain health, and exercise is especially known to play a beneficial role in AD treatment. However, the obvious but essential precondition for exercise is that the individual must physically able. AD is known to start as mild cognitive impairment and eventually progress to loss of motor function, eliminating the possibility of exercise. However, recent research on aging has suggested that parabiosis could have positive effects on cognitive function in the elderly. When plasma from young mice was infused into aged mice, behavioral tests, including those for contextual fear conditioning, spatial learning, and memory showed improvements in aging-related cognitive dysfunction [
15]. Conversely, when plasma from elderly mice was infused into young mice, neurogenesis, learning, and memory decreased [
31]. Yuan et al. [
32] reported that treatment with plasma from young mice reduced acute brain injury induced by aging-related hemorrhagic stroke. In one recent study, parabiosis and intravenous infusion of plasma from young mice resulted in near-complete recovery of synaptic and neural protein levels in an animal model of AD [
33]. These results suggest that factors carried in the blood might partially contribute to synaptic plasticity, neurogenesis, and cognitive function. In the present study, the young plasma group showed partial, trend-level improvements in hippocampal GSKβ/Tau expression, neuroplasticity, and mitochondrial function, but these were not statistically significant. Conversely, the group infused with plasma from mice that had exercised for 12 weeks showed overall improvements accompanied by positive effects on cognitive function. The effects of plasma from exercised mice may be due to elevated levels of BDNF in the blood resulting from exercise. Among the young plasma donor mice in this study, those that had exercised showed higher levels of plasma BDNF than those that had not exercised. Previous animal and clinical studies have also shown that blood BDNF levels increase after exercise [
34,
35]. Qin et al. [
36] reported that reduced peripheral blood BDNF is important clinical evidence of AD or mild cognitive impairment, supporting a relationship between decreasing BDNF level and AD progression. Specifically, plasma BDNF level can reflect hippocampal BDNF. Therefore, plasma BDNF level is an important and stable blood biomarker of AD [
37,
38].
From a neuroprotective stance, BDNF secreted at the synaptic cleft modulates neuroplasticity to confer protection from neural cell death caused by Aβ aggregates and tau protein, which are involved in the pathology of AD [
39]. In a study by Jiao et al. [
40], delivery of the BDNF gene was proposed to be a good treatment method for tau-related neural degeneration in AD and other tauopathy-related neurodegenerative diseases. BDNF is involved in the control of neurogenesis; normal BDNF-TrkB signaling is essential for the long-term survival of new neurons in the hippocampal dentate gyrus [
41] and can also inhibit caspase-3 activity as a result of apoptotic stimuli [
42]. Mitochondrial function in the brain is increased by BDNF in a dose-dependent manner, and BDNF counteracts damage caused by mitochondrial Ca
2+ overload [
43]. However, in the present study, plasma from young control and exercised mice failed to improve tau protein levels. In previous studies, heterochronic parabiosis and infusion of plasma from young mice improved synaptic and neuronal proteins as well as cognitive function in mutant mice for amyloid precursor protein without a decrease in Aβ burden [
33]. Meanwhile, BDNF supplementation relieved behavior deficits, protected against neuronal loss, and alleviated synaptic degeneration and neuronal abnormality in P301L mutant tau transgene mice, but had no effect on tau hyperphosphorylation [
40]. Consistent with previous studies on plasma infusion and BDNF, the present study found that infusion of plasma from exercised mice in an AD model did not reduce tau hyperphosphorylation but did enhance cognitive function via improvements in hippocampal synaptic proteins, neuroplasticity, including apoptosis, and mitochondrial function.
4. Material and Methods
4.1. Animals
All animal experiments were conducted according to the National Institutes of Health and National Institutes of Health and Korean Academy of Medical Sciences guidelines. The study protocol was approved by the Kyung Hee University Animal Care and Use Committee (Approval No. KHUASP [SE] -17-103, 14 August 2017). The mice were kept under constant temperature (25 ± 1 °C) and light (7 AM to 7 PM) conditions, and food and water were provided arbitrarily. The 12-month-old male mice were randomly divided into the following groups: wild type (CON), 3xTG-AD (AD), 3xTg-AD, young plasma injection (AD + YP), and 3xTg-AD and exercised young plasma injection (AD + EYP) groups (n = 10 in each group). The plasma used for the donation was obtained from 4-month-old C57BL/6 mice from the same mouse line that had undergone a 12-week exercise period. 3xTg-AD mice were obtained commercially from the Jackson Laboratory (MMRRC stock number 008880) and were maintained by breeding in our facilities. Genotypes were determined by PCR analysis of DNA collected from tail biopsies. BrdU (Sigma, St. Louis, MO, USA) was administered intraperitoneally (i.p.) at 100 mg/kg/day for 7 days, and the mice were sacrificed 4 weeks after the first day of BrdU injection to observe neurogenesis.
4.2. Plasma Donation Mice EXERCISE Protocol
The 4-week-old mice (C57BL/6) that would eventually be used for blood donation exercised on a treadmill for animals at an inclination of 0°. For the first 4 weeks, the animals performed 5 min of warm-up exercise at a speed of 3 m/min, followed by 30 min of the main exercise at a speed of 10 m/min, and finally 5 min of a cool-down exercise at a speed of 3 m/min. Thereafter, the exercise load of the main exercise was gradually increased to a speed of 11 m/min in weeks 5–6, 12 m/min in weeks 7–8, 13 m/min in weeks 9–10, and eventually 50 min of 14 m/min in weeks 11–12. Exercise was performed five times per week, for a total of 12 weeks.
4.3. Infusion of Young Plasma and Young Plasma from Exercised Mice
For young plasma infusion, we performed plasma infusion immediately after sacrificing 20, 4-month-old male donor mice each from the exercise and non-exercise groups, two mice every 3 days. As described previously [
15], the plasma was isolated by centrifugation and injected into the tail veins of 3xTg-AD mice in 100-µL doses, one dose every 3 days, for a total of 10 doses.
4.4. Behavioral Analysis
4.4.1. Morris Water Maze
Spatial learning and memory were analyzed using the Morris water maze task. One day before starting training, for acclimation, the animals were made to swim freely in the swimming pool for 60 s without an escape platform. Training (learning) consisted of the animals trying to find an escape platform, and was performed four times a day for 5 days. Animals that could not find the escape platform within 60 s were guided to the platform, while swimming, by the experimenter. The animals were allowed to rest for 30 s on the platform. A probe trial was performed 24 h after the last training session, in which animals were allowed to swim freely for 60 s with no escape platform. Video tracking was used to automatically measure how well the animals remembered the previous location of the escape platform.
4.4.2. Step-Through Avoidance Test
Long-term memory was measured using the step-through avoidance test. On the first day of training, the animals were placed on a platform brightly lit by a halogen lamp, and the door to a box was left open. Once the animal entered the box, the door was closed and the animal was allowed to remain inside the box for 20 s. This method was repeated twice. Finally, on the third trial, as soon as the door was closed, the animal was given a single 0.3 mA electrical shock for 2 s through the floor. After 24 h, the animal was placed on the brightly lit platform, and after the door to the box was opened, the time was measured until the animal entered the box (latency). The latency was measured up to 300 s, and animals that did not enter the box within this time were scored a latency of 300 s.
4.5. Preparation of Tissue
The animals were euthanized immediately after the water maze test. To prepare the brain slices, the mice were fully anesthetized with ethyl ether, perfused transcardially with 50 mM phosphate-buffered saline (PBS), and then fixed with a freshly prepared solution of 4% paraformaldehyde in 100 mM phosphate buffer (pH 7.4). The brains were then removed, post-fixed in the same fixative overnight, and transferred into a 30% sucrose solution for cryoprotection. Coronal sections with a thickness of 40 μm were created using a freezing microtome (Leica, Nussloch, Germany). From each group of 10 animals, five were used for immunohistochemistry and five for Western blot and mitochondrial function analysis. The hippocampal tissue for Western blot analysis was immediately stored at −70 °C until use. For immunohistochemistry, two sections from each group were analyzed, resulting in a total of 10 slices. Western blot was performed to analyze all five samples in each group and then was re-quantified for each protein and reanalyzed in the five samples. Therefore, the density value was calculated and analyzed a total of 10 times in each group.
4.6. Immunohistochemistry
To visualize cell proliferation expression, immunohistochemistry for doublecortin (DCX) in the dentate gyrus was performed. The sections were incubated in PBS for 10 min, and then washed three times for 5 min in the PBS. The sections were then incubated in 1% H2O2 for 30 min. The sections were selected from each brain and incubated overnight with goat anti-DCX antibody (1:500; Santa cruz, Dallas, TX, USA) and then with biotinylated secondary antibody (rabbit) (1:250; Vector Laboratories, Burlingame, CA, USA) for another 1.5 h. Signal from the secondary antibody was amplified with the Vector Elite ABC kit® (1:100; Vector Laboratories). Antibody-biotin-avidin-peroxidase complexes were visualized using a DAB substrate kit (Vector Laboratories). The slides were air-dried overnight at room temperature, and the coverslips were mounted using Permount ® (Fisher scientific, Fair lawn, NJ, USA).
4.7. Immunofluorescence
BrdU/NeuN-positive cells in the dentate gyrus were tested for immunofluorescence. In brief, the brain sections were permeabilized by incubation in 0.5% Triton X-100 in PBS for 20 min, then incubated in 50% formamide-2× standard saline citrate at 65 °C for 2 h, denaturated in 2 N HCl at 37 °C for 30 min, and rinsed twice in 100 mM sodium borate (pH 8.5). The sections were incubated overnight with a rat anti-BrdU antibody (1:500; Abcam, Cambridge, UK) and mouse anti-NeuN antibody (1:500; Millipore, Temecula, CA). The brain sections were then washed in PBS and incubated with the appropriate secondary antibodies for 1.5 h. The secondary antibodies used were anti-mouse IgG Alexa Fluor-488 and anti-rat IgG Alexa Fluor-550. Images were captured using an FV3000 confocal microscope (Olympus, Tokyo, Japan).
4.8. TUNEL Staining
To visualize DNA fragmentation, we performed TUNEL staining using an In Situ Cell Death Detection Kit (Roche Diagnostics, Risch-Rotkreuz, Switzerland) according to the manufacturer’s protocol. The sections were post-fixed in ethanol-acetic acid (2:1), rinsed, incubated with proteinase K (100 mg/mL), and then rinsed again. Next, the sections were incubated in 3% H2O2, permeabilized with 0.5% Triton X-100, rinsed again, and incubated in the TUNEL reaction mixture. The sections were rinsed and visualized using Converter-POD with 0.03% DAB, counterstained with Nissl, and mounted onto gelatin-coated slides. The slides were air-dried overnight at room temperature and cover-slipped using Permount mounting medium.
4.9. Western Blotting
The hippocampal tissues were homogenized on ice and lysed in a lysis buffer containing 50 mM Tris–HCl (pH 7.5), 150 mM NaCl, 0.5% deoxycholic acid, 1% Nonidet P40, 0.1% sodium dodecyl sulfate, 1 mM PMSF, and leupeptin 100 mg/mL. The protein content was measured using a colorimetric protein assay kit (Bio-Rad, Hercules, CA, USA). Thirty micrograms of protein were separated on sodium dodecyl sulfate-polyacrylamide gels and transferred onto a nitrocellulose membrane, which was incubated with antibodies against β-actin (1:2000; Santa Cruz Biotechnology), GAPDH (1:2000; Santa Cruz Biotechnology), t-GSK3β, p-GSK3β (ser 9) (1:1000; Cell Signaling), t-Tau, p-Tau (ser262) (1:1000; Thermo Fisher), p-tau (thr 205) (1:1000; Thermo Fisher), Bcl-2 (1;1000; Santa Cruz Biotechnology), cytochrome c (1:1000; Santa Cruz Biotechnology), Bax (1:1000; Cell Signaling), cleaved caspase-3,-9 (1:700; Cell Signaling), BDNF (1:1000; Alomone), PSD95 (1:1000; Cell Signaling), and synaptophysin (1:1000; Abcam). Horseradish peroxidase-conjugated anti-mouse antibodies for Bcl-2, p-Tau, cytochrome c, β-actin and GAPDH, and anti-rabbit antibodies for t-tau, t-GSK3β, p-GSK3β, Bax, cleaved caspase-3, BDNF, PSD95, and synaptophysin were used as secondary antibodies.
4.10. Mitochondrial Ca2+ Retention Capacity
The mitochondrial calcium retention capacity was tested to assess the susceptibility of the permeability transition pore (PTP) to opening. Briefly, after grinding the hippocampal tissue, overlaid traces of changes in fluorescence induced by Calcium Green-5 N were measured continuously (ΔF/min) at 37 °C during state 4 respiration using a Spex FluoroMax 4 spectrofluorometer (Horiba Scientific, Edison, NJ, USA). After establishing the background ΔF (hippocampal tissue in the presence of 1 μM Calcium Green-5 N, 1 U/mL hexokinase, 0.04 mM EGTA, 1.5 nM thapsigargin, 5 mM 2-deoxyglucose, 5 mM glutamate, 5 mM succinate, and 2 mM malate), the reaction was initiated by addition of Ca2+ pulses (12.5 nM), with excitation and emission wavelengths set at 506 and 532 nm, respectively. The total mitochondrial calcium retention capacity prior to PTP opening (i.e., release of Ca2+) was expressed as pmol/mg tissue weight.
4.11. Mitochondrial H2O2 Emission
The mitochondrial H2O2 emission was measured at 37 °C (ΔF/min) during state 4 respiration (10 μg/mL oligomycin) by continuously monitoring oxidation of Amplex Red (excitation/emission λ = 563/587 nm) using a Spex FluoroMax 4 spectrofluorometer with the following protocol: 10 μM Amplex Red, 1 U/mL horseradish peroxidase, and 10 μg/mL oligomycin; followed by 1 mM malate + 2 mM glutamate (complex I substrates); 3 mM succinate (complex II substrate); and 10 mM glycerol-3-phosphate (lipid substrate). The mitochondrial H2O2 emission rate after removing the background value from each of the standard values (standard curve) was calculated from the ΔF/min gradient values and expressed as pmol/min/mg tissue weight.
4.12. Plasma BDNF Analysis in Donation Mice
The plasma BDNF concentration was measured using ELISA. The ELISA kit was purchased from R & D Biology Inc. (Total BDNF Quantikine ELISA kit DBNT00, R & D Systems), and the experiment was performed strictly according to the manufacturer’s instructions. The specific protocol was as follows: first, the reagents, samples, and standard products were prepared. The samples and standard products were added and reacted for 120 min at 37 °C. After washing the plate three times, antibody working solution was added and the mixture was left to react for 60 min at 37 °C. The plate was washed three times again, horseradish peroxidase (HRP) was added, and the mixture was left to react for 30 min at 37 °C. After washing the plate three times, substrate working solution was added, and the mixture was left to react in a dark place for 5–10 min. After adding stop buffer, a BioTek ELx800 full-automatic enzyme labeling system ( Winooski, VT, USA) was used to detect the optical density (OD) at 450 nm within 30 min.
4.13. Statistical Analysis
Cell counting and optical density quantification for TUNEL, DCX, and BrdU/NeuN-positive cells were performed using Image-Pro® Plus (Media Cyberbetics Inc. Rockville, MD, USA) attached to a light microscope (Olympus, Tokyo, Japan). The data were analyzed with one-way ANOVA, followed by Tukey post-hoc tests. Plasma BDNF was analyzed using t-tests. All values are expressed as the mean ± standard error of the mean (S.E.M.), and p-values < 0.05 were considered significant.